Drug in adhesive type transdermal matrix systems of ondansetron hydrochloride: optimization of permeation pattern using response surface methodology

References

• Barry BW. (2004). Breaching the skin’s barrier to drugs. Nat Biotechnol, 22, 165–167.
   PubMed Web of Science ®Google Scholar
• Bodea A, Leucuta SE. (1997). Optimization of hydrophilic matrix tablets using a d-optimal design. Int J Pharm, 153, 247–255.
   Web of Science ®Google Scholar
• Bozigian HP, Pritchard JF, Gooding AE, Pakes GE. (1994). Ondansetron absorption in adults: effect of dosage form, food, and antacids. J Pharm Sci, 83, 1011–1013.
   PubMed Web of Science ®Google Scholar
• Butcher ME. (1993). Global experience with ondansetron and future potential. Oncology, 50, 191–197.
   PubMed Web of Science ®Google Scholar
• Chien YW. (1982). Novel Drug Delivery Systems ( pp. 160–161). New York: Marcel Dekker.
   Google Scholar
• Cho E, Gwak H, Chun I. (2008). Formulation and evaluation of ondansetron nasal delivery systems. Int J Pharm, 349, 101–107.
   PubMed Web of Science ®Google Scholar
• Cornell JA. (1990). Designs Models and the Analysis of Mixture Data ( pp. 188–236). 2nd ed. New York: John Wiley & Sons.
   Google Scholar
• Draize JH, Woodard G, Calvery HO. (1944). Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther, 82, 377–390.
   Web of Science ®Google Scholar
• Eriksson L, Johansson E, Wikstrom C. (1998). Mixture design: design generation, PLS analysis and model usage. Chemomet Intell Lab Syst, 43, 1–24.
   Web of Science ®Google Scholar
• Figg WD, Dukes GE, Pritchard JF, Hermann DJ, Lesesne HR, Carson SW, Songer SS, Powell JR, Hak LJ. (1996). Pharmacokinetics of ondansetron in patients with hepatic insufficiency. J Clin Pharmacol, 36, 206–215.
   PubMed Web of Science ®Google Scholar
• Fischer W, Stierle A. (2002). Transdermal systems for release of 5-HT3 receptor antagonists and their use in anti-emetic treatment. Novosis Pharma AG assignee, United States Patent no. 6,440,453 B1.
   Google Scholar
• Funke AP, Gunther C, Muller RH, Lipp R. (2002). In vitro release and transdermal fluxes of a highly lipophilic drug and of enhancers from matrix TDS. J Control Rel, 82, 63–70.
   PubMed Web of Science ®Google Scholar
• Gupta SP, Jain S. K. (2006). Transdermal atenolol releasing system: an approach towards its development. J Drug Target, 14, 607–613.
   PubMed Web of Science ®Google Scholar
• Gwak HS, Oh SI, Chun KI. (2003). In vitro percutaneous absorption of ondansetron hydrochloride from pressure-sensitive adhesive matrices through hairless mouse skin. Arch Pharm Res, 26, 644–648.
   PubMed Web of Science ®Google Scholar
• Hesketh PJ, Gandara DR. (1991). Serotonin antagonists: a new class of antiemetic agents. J Natl Cancer Inst, 83, 613–620.
   PubMed Web of Science ®Google Scholar
• Hsyu PH, Pritchard JF, Bozigian HP, Lloyd TL, Griffin RH, Shamburek R, Krishna G, Barr WH. (1994). Comparison of the pharmacokinetics of an ondansetron solution (8 mg) when administered intravenously, orally, to the colon, and to the rectum. Pharm Res, 11, 156–159.
   PubMed Web of Science ®Google Scholar
• Hussain AA, Dakkuri A, Itoh S. (2000). Nasal absorption of ondansetron in rats: an alternative route of drug delivery. Cancer Chemother Pharmacol, 45, 432–434.
   PubMed Web of Science ®Google Scholar
• Keshary PR, Chien YW. (1984). Mechanism of transdermal controlled nitroglycerin administration. Part 2. Assessment of rate controlling steps. Drug Dev Ind Pharm, 10, 1663–1699.
   Web of Science ®Google Scholar
• Krishna R, Pandit JK. (1994). Transdermal delivery of propranolol. Drug Dev Ind Pharm, 20, 2459–2465.
   Web of Science ®Google Scholar
• Lewis GA, Mathieu D, Phan-Tan-Luu R. (1999). Response surface methodology. In: Pharmaceutical Experimental Design (pp. 185–246). New York: Marcel Dekker Inc.
   Google Scholar
• McKenzie R, Kovac A, O’Connor T, Duncalf D, Angel J, Gratz I, Tolpin E, McLeskey C, Joslyn A. (1993). Comparison of ondansetron versus placebo to prevent postoperative nausea and vomiting in women undergoing ambulatory gynecologic surgery. Anesthesiology, 78, 21–28.
   PubMed Web of Science ®Google Scholar
• Melas VB. (2006). Functional Approach to Optimal Experimental Design (pp. 197–228). New York: Springer.
   Google Scholar
• Mukherjee B, Mahapatra S, Gupta R, Patra B, Tiwari A, Arora P. (2005). A comparison between povidone-ethylcellulose and povidone-eudragit transdermal dexamethasone matrix patches based on in vitro skin permeation. Eur J Pharm Biopharm, 59, 475–483.
   PubMed Web of Science ®Google Scholar
• Myers RH, Montgomery DC. (2002). Response Surface Methodology: Process and Product Optimization Using Designed Experiments (pp. 273–286). New York: John Wiley & Sons.
   Google Scholar
• Pattnaik S, Swain K, Mallick S. (2009). Influence of polymeric system and loading dose on drug release from alfuzosin hydrochloride transdermal films. Lat Am J Pharm, 28, 62–69.
   Web of Science ®Google Scholar
• Rolia F, Del Favero A. (1995). Ondansetron clinical pharmacokinetics. Clin Pharmacokinet, 29, 95–109.
   PubMed Web of Science ®Google Scholar
• Scuderi P, Wetchler B, Sung YF, Mingus M, DuPen S, Claybon L, Leslie J, Talke P, Apfelbaum J, Sharifi-Azad S. (1993). Treatment of postoperative nausea and vomiting after outpatient surgery with the 5-HT3 antagonist ondansetron. Anesthesiology, 78, 15–20.
   PubMed Web of Science ®Google Scholar
• Sherertz EF, Solan KB, McTiernan RG. (1987). Effect of skin pretreatment with vehicle alone or drug in vehicle on flux of a subsequently applied drug: results of hairless mouse skin and diffusion cell studies. J Invest Dermatol, 89, 249–252.
   PubMed Web of Science ®Google Scholar
• Swain K, Pattnaik S, Mallick S, Chowdary KA. (2009). Influence of hydroxypropyl methylcellulose on drug release pattern of a gastroretentive floating drug delivery system using a 32 full factorial design. Pharm Dev Technol, 14, 193–198.
   PubMed Web of Science ®Google Scholar
• Tiwary AK, Sapra B, Jain S. (2007) Innovations in transdermal drug delivery: formulations and techniques Recent Pat Drug Deliv Formul, 1, 23–36.
   Google Scholar
• Yadav AK, Mishra P, Agrawal GP. (2008). Use of microparticulate systems to accelerate skin wound healing: an insight on hyaluronic acid in drug targeting and drug delivery. J Drug Target, 16, 91–107.
   PubMed Web of Science ®Google Scholar
• Zhan X, Tang G, Chen S, Mao Z. (2006). A new copolymer membrane controlling clonidine linear release in a transdermal drug delivery system. Int J Pharm, 322, 1–5.
   PubMed Web of Science ®Google Scholar